| dc.contributor.author | Ethiopian Food and Drug Authority | |
| dc.date.accessioned | 2026-02-24T08:45:33Z | |
| dc.date.available | 2026-02-24T08:45:33Z | |
| dc.date.issued | 2025 | |
| dc.identifier.uri | http://repository.iphce.org/xmlui/handle/123456789/5349 | |
| dc.description.abstract | The Ethiopian Food and Drug Authority (EFDA), under Proclamation 1112/2019, regulates all medicinal products, including plasma-derived biological products. Article 30(3) of the proclamation mandates that blood and blood components intended for transfusion or further processing must comply with stringent safety and quality standards before use. | en_US |
| dc.language.iso | en_US | en_US |
| dc.subject | Medical supplies | en_US |
| dc.title | Guideline for the registration of plasma derived medical products | en_US |
| dc.type | Guideline | en_US |